Skip to content

Phase I study of IAG933 in patients with advanced Mesothelioma and other solid tumors

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-508369-34-00
Acronym
CIAG933A12101
Enrollment
89
Registered
2024-02-20
Start date
2021-12-07
Completion date
Unknown
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced mesothelioma or other solid tumors harboring certain molecular alterations in the Hippo pathway

Interventions

None listed

Sponsors

Novartis Pharma AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Germany, Italy, Netherlands, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026